D.A. Davidson & Co’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

D.A. Davidson & Co’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,340	Closed	-$81K	–	2363
2015 Q1	$81K	Sell	2,340 -466	-17%	-$15.8K	﹤0.01%	1236
2014 Q4	$89K	Sell	2,806 -47	-2%	-$1.36K	﹤0.01%	1191
2014 Q3	$79K	Sell	2,853 -117	-4%	-$3.56K	﹤0.01%	1227
2014 Q2	$89K	Sell	2,970 -105	-3%	-$2.9K	﹤0.01%	1203
2014 Q1	$84K	Sell	3,075 -197	-6%	-$5.16K	﹤0.01%	1218
2013 Q4	$82K	Sell	3,272 -140	-4%	-$4.31K	﹤0.01%	1153
2013 Q3	$101K	Sell	3,412 -528	-13%	-$14.7K	﹤0.01%	889
2013 Q2	$112K	Buy	+3,940	New	+$109K	0.01%	839

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

D.A. Davidson & Co's BRLI Position: Q2 2015 in Review

D.A. Davidson & Co sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 2,340 shares — an estimated $81K sold.

D.A. Davidson & Co first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $112K in Q2 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

D.A. Davidson & Co reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
D.A. Davidson & Co sold 2,340 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $81K.
D.A. Davidson & Co first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
D.A. Davidson & Co's BIO-REFERENCE LABS INC-NEW- position peaked at $112K in Q2 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on D.A. Davidson & Co's 13F filing for Q2 2015, filed 14 Aug 2015.